title: Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results.
authors: Christie Hospital, Manchester, U.K.
authors: N
authors: N
authors: Thatcher
authors: P
authors: P
authors: Taylor
authors: K B
authors: KB
authors: Carroll
authors: E M
authors: EM
authors: Loriaux
authors: P
authors: P
authors: Palmer
authors: C R
authors: CR
authors: Franks
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D007262:Infusions, Intravenous; D007263:Infusions, Parenteral; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000009:adverse effects; D008175:Lung Neoplasms / Q000188:drug therapy*; D008654:Mesothelioma / Q000188:drug therapy*; D010994:Pleura; D010997:Pleural Neoplasms / Q000188:drug therapy*
chemical_list: D007376:Interleukin-2